Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-12-18
2000-09-19
Davis, Zinna Northington
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546147, C07D21716, A61K 3147
Patent
active
061212822
ABSTRACT:
This invention provides 1,2,3,4-tetrahydroisoquinoline compounds and their pharmaceuticallyacceptable salts, pharmaceutical formulations of said compounds, and methods for treating hyperglycemia associated with non-insulin dependent diabetes and for treating hyperlipidemia.
REFERENCES:
patent: 4902695 (1990-02-01), Ornstein
patent: 4988720 (1991-01-01), Cawthorne et al.
patent: 5036079 (1991-07-01), Clark et al.
patent: 5236934 (1993-08-01), VanAtten
patent: 5246943 (1993-09-01), Blankley et al.
patent: 5306726 (1994-04-01), Hulin
patent: 5350757 (1994-09-01), Blankley et al.
patent: 5489686 (1996-02-01), Blankley et al.
patent: 5525614 (1996-06-01), Blankley et al.
patent: 5616819 (1997-04-01), Boyce et al.
J.E. Gerich in New Engl. J. Med., 321, 1231-1245 (1989).
Diabetes Care, 18, Supplement 1, 86-93 (1995).
Ellingboe, et al., J. Med. Chem. 36:2485-2493 (1993).
Sonntag, Chem. Rev. 52:258-294 (1953).
Ugi, et al, Agnew. Chem. Intern. Ed. Engl. 4:472-484 (1965); also Mar. pp. 777-778.
Bose, A.K., et al., J. Can. Chem., 62:2498 (1984).
Cantello, et al., J. Med. Chem, 37:3977-3985 (1994).
C.W. Still, et al., J. Org. Chem. 43:2923 (1989).
Letsinger, R.L. and Ogilvie, K.K.; J. Org. Chem. 32:296 (1967).
Kugel, C., Lellouche, J.-P. and Beaucourt, J.-P., Tetrahedron Lett. 30:4947 (1989).
Arrieta, A. and Palmo, C., Synthesis (1982) 1050.
J. Med. Chem. 35:2617 (1992).
Dominianni Samuel James
Gritton William Harlan
Darkes Paul R.
Davis Zinna Northington
Eli Lilly and Company
Ginah Francis O.
Kelley James J.
LandOfFree
Hypoglycemic and hypolipidemic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hypoglycemic and hypolipidemic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypoglycemic and hypolipidemic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1073555